
Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023
Basic Account
Get to know the platform
You only have access to basic statistics.
Starter Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$69 USD $49 USD / Month *
in the first 12 months
Professional Account
Full access
Business Solutions including all features.
* Prices do not include sales tax.
Other statistics that may interest you
Pandemic situation
5
- Basic Statistic New cases of COVID-19 worldwide from January 23, 2020 to April 25, 2023, by day
- Basic Statistic Critical COVID-19 cases in most impacted countries worldwide as of December 22, 2022
- Basic Statistic Rate of COVID-19 cases in most impacted countries worldwide as of December 22, 2022
- Basic Statistic COVID-19 deaths worldwide as of May 2, 2023, by country and territory
- Basic Statistic COVID-19 cases and deaths per million in 210 countries as of July 13, 2022
Search for vaccines
7
- Basic Statistic Biotechs: duration of COVID-19 response compared to previous health threats 2003-2019
- Premium Statistic BARDA funding for the development of COVID-19 vaccines in the U.S. 2021
- Premium Statistic Shareholdings at select COVID-19 vaccine companies by investor 2021
- Basic Statistic COVID-19 vaccine comparison adverse events Biontech vs Moderna 2020
- Basic Statistic Number of COVID-19 drugs in development worldwide by phase June 2022
- Premium Statistic Top companies by COVID-19 treatment vaccines in development June 2022
- Basic Statistic Number of COVID-19 treatment vaccine trials worldwide by type June 2022
Leading products and companies
7
- Basic Statistic Forecasted sales of select COVID-19 vaccines worldwide 2021-2022
- Basic Statistic Bestselling COVID-19 vaccines and drugs worldwide in 1st HY 2021
- Premium Statistic Pfizer's revenue by segment 2022
- Basic Statistic Revenue of BioNTech 2017-2022
- Basic Statistic Moderna's revenue 2016-2022
- Basic Statistic AstraZeneca's revenue by therapeutic area 2020-2022
- Premium Statistic Sales of Johnson & Johnson worldwide 2011-2022, by segment
Vaccination campaign
5
- Basic Statistic COVID-19 vaccine doses administered worldwide as of March 20, 2023, by country
- Basic Statistic COVID-19 vaccine dose rate worldwide by select country or territory March 20, 2023
- Basic Statistic COVID-19 vaccine dose numbers by top manufacturer 2021
- Basic Statistic COVID-19 vaccines contract size in doses by country and region 2021
- Basic Statistic Share of population covered under COVID vaccine contracts as of Mar. 2021, by country
Distribution inequality
5
- Basic Statistic COVID-19 vaccine doses administered worldwide 2021, by country income group
- Premium Statistic Pfizer/BioNTech COVID-19 vaccines delivered by country income group 2021
- Premium Statistic Share of Moderna COVID-19 vaccines delivered by country income group 2021
- Basic Statistic AstraZeneca COVID-19 vaccines delivered worldwide by country income group 2021
- Basic Statistic Johnson & Johnson COVID-19 vaccines delivered worldwide by country group 2021
Vaccination approval and willingness
8
- Premium Statistic U.S. approval of pharma companies' COVID-19 vaccine development handling 2021
- Basic Statistic COVID-19 vaccine and willingness among U.S. adults Dec 2020 - Apr 2022
- Basic Statistic COVID-19 vaccination and intent among younger U.S. adults, Mar-May 2021, by age
- Basic Statistic Canadian confidence in government's COVID-19 vaccine distribution as of Mar. 2021
- Basic Statistic Brazil: intention to get immunized against COVID-19 2021
- Basic Statistic COVID-19: main reasons for not getting vaccinated in Spain 2022
- Premium Statistic Public attitudes on COVID-19 vaccines developed by different countries in China 2020
- Premium Statistic Global attitudes on COVID-19 vaccines developed in China 2020
Further related statistics
15
- Attitude of Hungarians towards getting vaccinated against the coronavirus 2020
- Survey on the acceptance of the coronavirus vaccine in Spain 2021
- Leading COVID-19 drugs, therapies and vaccines in development by early results 2020
- Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- COVID-19-related research market cap changes in biopharma companies Feb 2020
- Coronavirus-related share price changes in biopharma companies Jan-Feb 2020
- COVID-19 vaccine origin preference in Russia 2020, by age
- Reasons against getting a COVID-19 vaccine in Russia 2020
- Types of precautions taken by individuals against coronavirus in the UK 2020
- Changes in outpatient prescriptions in Gyeonggi/Incheon/Gangwon South Korea 2020
- Active coronavirus (COVID-19) cases in Hungary 2020-2021
- Changes in outpatient prescriptions during COVID-19 in Seoul South Korea 2020
- Impact of COVID-19 on pharmacy operations in South Korea 2020
- Number of coronavirus (COVID-19) cases in Bosnia and Herzegovina 2023
Further Content: You might find this interesting as well
Statistics
- Attitude of Hungarians towards getting vaccinated against the coronavirus 2020
- Survey on the acceptance of the coronavirus vaccine in Spain 2021
- Leading COVID-19 drugs, therapies and vaccines in development by early results 2020
- Impact of COVID-19 on revenue of hospitality and retail sector South Korea 2020
- Changes in outpatient prescriptions in Gwangju and Jeolla South Korea 2020
- COVID-19-related research market cap changes in biopharma companies Feb 2020
- Coronavirus-related share price changes in biopharma companies Jan-Feb 2020
- COVID-19 vaccine origin preference in Russia 2020, by age
- Reasons against getting a COVID-19 vaccine in Russia 2020
- Types of precautions taken by individuals against coronavirus in the UK 2020
- Changes in outpatient prescriptions in Gyeonggi/Incheon/Gangwon South Korea 2020
- Active coronavirus (COVID-19) cases in Hungary 2020-2021
- Changes in outpatient prescriptions during COVID-19 in Seoul South Korea 2020
- Impact of COVID-19 on pharmacy operations in South Korea 2020
- Number of coronavirus (COVID-19) cases in Bosnia and Herzegovina 2023
The Guardian. (March 6, 2021). Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023 [Graph]. In Statista. Retrieved June 08, 2023, from https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian. "Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023." Chart. March 6, 2021. Statista. Accessed June 08, 2023. https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian. (2021). Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023. Statista. Statista Inc.. Accessed: June 08, 2023. https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian. "Prices and Sales Forecasts for Major Covid-19 Vaccines from 2021 to 2023." Statista, Statista Inc., 6 Mar 2021, https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/
The Guardian, Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023 Statista, https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/ (last visited June 08, 2023)
Prices and sales forecasts for major COVID-19 vaccines from 2021 to 2023 [Graph], The Guardian, March 6, 2021. [Online]. Available: https://www.statista.com/statistics/1221576/covid-vaccines-sales-forecast-mean-price-share-growth/